Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2018-03-12 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第五届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a board meeting resolution by 嘉事堂药业股份有限公司. It details the approval of a proposal to use idle raised funds temporarily to supplement working capital, including voting results and references to related announcements published elsewhere. The document is short (906 characters) and does not contain financial statements or detailed financial data. It is an announcement of a board decision rather than a full management report or financial report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2018-03-12 Chinese
华泰联合证券有限责任公司关于公司使用闲置募集资金暂时补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities Co., Ltd., acting as the sponsor for Jiashitang Pharmaceutical Co., Ltd., regarding the company's use of idle raised funds to temporarily supplement working capital. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, discusses the non-public issuance of shares, the raised funds, their intended use, and the company's compliance with relevant laws and procedures. The document includes audit and verification opinions but does not contain financial statements or quarterly/yearly financial results. It is a formal verification or audit opinion related to the use of raised funds, which fits the category of an Audit Report / Information (AR) rather than an announcement or a full annual/interim report. The document length is 4131 characters, which is substantial and contains detailed content, not just a brief announcement. Therefore, the best classification is AR with high confidence. FY 2018
2018-03-12 Chinese
2017年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2017 年度业绩快报' which translates to '2017 Annual Performance Express Report' or '2017 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2017, including revenue, profit, net profit attributable to shareholders, earnings per share, and other financial metrics. The document explicitly states that the data is preliminary, internally audited but not yet audited by an external accounting firm, and may differ from the final annual report. It also includes a brief explanation of business performance and financial condition during the period. The document length is 1743 characters, which is relatively short and suggests it is a summary or quick report rather than a full detailed annual report. The content matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or annual financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. It is not a Report Publication Announcement (RPA) because it contains actual financial data, not just a notice of report availability. Therefore, the correct classification is Earnings Release (ER). FY 2017
2018-02-23 Chinese
2018年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2018 first extraordinary general meeting (EGM) of shareholders of 嘉事堂药业股份有限公司. It details the legality and compliance of the meeting's convening, attendance, voting procedures, and results. The document includes specific resolutions passed, such as changes in directors and supervisors, and approval of credit applications. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a shareholders meeting. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA) because it reports official voting results and related legal opinions on the shareholder meeting resolutions.
2018-02-08 Chinese
2018年第一次临时股东大会会议决议暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions and voting results from the 2018 first extraordinary general meeting (临时股东大会) of 嘉事堂药业股份有限公司. It details the meeting date, attendance, voting results on various proposals including board member elections and credit applications, and includes a legal opinion on the meeting's validity. The document is not a full report but a formal announcement of voting results and meeting resolutions. It fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 3103 characters, consistent with an announcement rather than a full report.
2018-02-08 Chinese
第五届监事会第十六次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the 16th meeting of the 5th Supervisory Board of the company, including the election of the Supervisory Board Chairman. It contains no financial data, no report or presentation, and no voting results from a general meeting. It is a formal announcement about board/management changes, specifically the election of a supervisory board chairman, which falls under Board/Management Information (MANG). The document length is short and focused on management election, not a report or regulatory filing.
2018-02-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.